Investor

MindSEED ApS is a dynamic medical device startup that specializes in developing wearable EEG technology for non-invasive decentralized monitoring of temporal lobe brain activity. Our goal is to provide the next generation of medical devices with advances in digital diagnostics that enable patients and doctors to receive better care.
The company has received a total of Euro 100,000 in funding from Innovation Fund Denmark and its founders, which has helped to bring our product closer to commercialization. As a pre-revenue company, we are committed to developing a unique intellectual property that will help us stand out in the market.
Our team is composed of experienced professionals with a proven track record of success within medical devices and growth companies. We bring together expertise in neuroscience, engineering, software development, and manufacturing to ensure that we deliver a top-of-the-line product that meets the needs of both patients and healthcare providers.
At MindSEED ApS, we recognize that strategic partnerships with market leaders and investors are critical for the continued success of our company. That’s why we have teamed up with London-based Axial Capital Partners to manage our investor relations. With over a decade of experience in corporate finance and early-stage investments, Axial Capital Partners brings valuable insights and expertise to help us achieve our goals.

Our device is designed with state-of-the-art sensors that detect and interpret brain activity in real-time, providing valuable and actionable insights for both patients and care providers. The placement of our EEG electrodes behind the ear is a novel approach that has been validated in a clinical setting through a single-patient study at the Center for Neurology in Aarhus. This study found a 78% data fidelity compared to the EEG 10-20 golden standard and reference instrument.

Our technology incorporates machine learning to accurately identify the onset of seizures, providing personalized and accurate digital diagnostics with over 95% accuracy. The data is then collected and stored in the European Data Format (EDF) for seamless integration into current health platforms.
By providing better care for an underserved group, we are making a tangible impact on two of the United Nations’ Sustainable Development Goals: SDG3 (good health and well-being) and SDG4 (quality education). Our device is designed to be non-stigmatizing and user-friendly, making it an accessible solution for children and youth who need it most.

Our team brings years of expertise in medical devices, consumer electronics, and manufacturing to ensure that the needs of both patients and healthcare providers are met. We are committed to developing a device that is comfortable, easy to use, and non-stigmatizing, transforming how patient care is given and developed.
Join us on our mission to transform epilepsy care and improve patient outcomes. Contact us today to learn more about how our innovative technology can help make a difference in the lives of millions of patients worldwide.